Literature DB >> 15448574

Instrumented assessment of muscle overactivity and spasticity with dynamic polyelectromyographic and motion analysis for treatment planning.

Alberto Esquenazi1, Nathaniel H Mayer.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15448574     DOI: 10.1097/01.phm.0000141127.63160.3e

Source DB:  PubMed          Journal:  Am J Phys Med Rehabil        ISSN: 0894-9115            Impact factor:   2.159


× No keyword cloud information.
  11 in total

1.  Hypertonia in children: how and when to treat.

Authors:  Terence D Sanger
Journal:  Curr Treat Options Neurol       Date:  2005-11       Impact factor: 3.598

2.  Respective Contributions of Instrumented 3D Gait Analysis Data and Tibial Motor Nerve Block on Presurgical Spastic Equinus Foot Assessment: A Retrospective Study of 40 Adults.

Authors:  Camille Cormier; Clément Sourisseau; Emmeline Montane; Marino Scandella; Evelyne Castel-Lacanal; Xavier De Boissezon; Philippe Marque; David Gasq
Journal:  Front Neurol       Date:  2022-05-27       Impact factor: 4.086

3.  Hindlimb spasticity after unilateral motor cortex lesion in rats is reduced by contralateral nerve root transfer.

Authors:  Haiyang Zong; Fenfen Ma; Laiyin Zhang; Huiping Lu; Jingru Gong; Min Cai; Haodong Lin; Yizhun Zhu; Chunlin Hou
Journal:  Biosci Rep       Date:  2016-12-23       Impact factor: 3.840

4.  Patient Registry of Spasticity Care World: Data Analysis Based on Physician Experience.

Authors:  Alberto Esquenazi; Stella Lee; Nathaniel Mayer; Roser Garreta; Atul Patel; Elie Elovic; Stephen Koelbel; Gerard Francisco; Iris Reuter
Journal:  Am J Phys Med Rehabil       Date:  2017-12       Impact factor: 2.159

5.  Botulinum toxin treatment of spasticity targeted to muscle endplates: an international, randomised, evaluator-blinded study comparing two different botulinum toxin injection strategies for the treatment of upper limb spasticity.

Authors:  Tiina Rekand; Bo Biering-Sörensen; Jun He; Ole Jakob Vilholm; Peter Brøgger Christensen; Trandur Ulfarsson; Roger Belusa; Torbjörn Ström; Peter Myrenfors; Pascal Maisonobe; Torben Dalager
Journal:  BMJ Open       Date:  2019-05-05       Impact factor: 2.692

6.  Efficacy and Safety of AbobotulinumtoxinA for the Treatment of Hemiparesis in Adults with Lower Limb Spasticity Previously Treated With Other Botulinum Toxins: A Secondary Analysis of a Randomized Controlled Trial.

Authors:  Alberto Esquenazi; Gaëtan Stoquart; Peter Hedera; Luis Jorge Jacinto; Ugo Dimanico; Francois Constant-Boyer; Allison Brashear; Anne-Sophie Grandoulier; Claire Vilain; Philippe Picaut; Jean-Michel Gracies
Journal:  PM R       Date:  2020-03-27       Impact factor: 2.298

7.  Added Value of Dynamic EMG in the Assessment of the Equinus and the Equinovarus Foot Deviation in Stroke Patients and Barriers Limiting Its Usage.

Authors:  Isabella Campanini; Michela Cosma; Mario Manca; Andrea Merlo
Journal:  Front Neurol       Date:  2020-11-19       Impact factor: 4.003

8.  Surgical Intervention for Spastic Upper Extremity Improves Lower Extremity Kinematics in Spastic Adults: A Collection of Case Studies.

Authors:  Nojoud AlHakeem; Elizabeth Anne Ouellette; Francesco Travascio; Shihab Asfour
Journal:  Front Bioeng Biotechnol       Date:  2020-02-21

9.  Individualized OnabotulinumtoxinA Treatment for Upper Limb Spasticity Resulted in High Clinician- and Patient-Reported Satisfaction: Long-Term Observational Results from the ASPIRE Study.

Authors:  Gerard E Francisco; Wolfgang H Jost; Ganesh Bavikatte; Daniel S Bandari; Simon F T Tang; Michael C Munin; Joan Largent; Aubrey M Adams; Aleksej Zuzek; Alberto Esquenazi
Journal:  PM R       Date:  2020-02-27       Impact factor: 2.298

10.  Long-Term Observational Results from the ASPIRE Study: OnabotulinumtoxinA Treatment for Adult Lower Limb Spasticity.

Authors:  Alberto Esquenazi; Ganesh Bavikatte; Daniel S Bandari; Wolfgang H Jost; Michael C Munin; Simon Fuk Tan Tang; Joan Largent; Aubrey Manack Adams; Aleksej Zuzek; Gerard E Francisco
Journal:  PM R       Date:  2021-01-11       Impact factor: 2.298

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.